These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36589188)

  • 21. Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment.
    Bauer M; Demyttenaere K; El-Khalili N; Thase ME; Papakostas GI; Szamosi J; Earley WR; Eriksson H
    Int Clin Psychopharmacol; 2014 Jan; 29(1):16-25. PubMed ID: 24108148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants.
    Wu E; Greenberg P; Yang E; Yu A; Ben-Hamadi R; Erder MH
    Curr Med Res Opin; 2008 Oct; 24(10):2805-13. PubMed ID: 18755054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders: a longitudinal and prospective study.
    Benítez CI; Smith K; Vasile RG; Rende R; Edelen MO; Keller MB
    Am J Geriatr Psychiatry; 2008 Jan; 16(1):5-13. PubMed ID: 18165458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatrician and family physician prescription of selective serotonin reuptake inhibitors.
    Rushton JL; Clark SJ; Freed GL
    Pediatrics; 2000 Jun; 105(6):E82. PubMed ID: 10835095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between Selective Serotonin Reuptake Inhibitor Therapy and Suicidality: Analysis of U.S. Food and Drug Administration Adverse Event Reporting System Data.
    Umetsu R; Abe J; Ueda N; Kato Y; Matsui T; Nakayama Y; Kinosada Y; Nakamura M
    Biol Pharm Bull; 2015; 38(11):1689-99. PubMed ID: 26521821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between warfarin combined with serotonin-modulating antidepressants and increased case fatality in primary intracerebral hemorrhage: a population-based study.
    Löppönen P; Tetri S; Juvela S; Huhtakangas J; Saloheimo P; Bode MK; Hillbom M
    J Neurosurg; 2014 Jun; 120(6):1358-63. PubMed ID: 24506245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suicidality and self-injury with selective serotonin reuptake inhibitors in youth: Occurrence, predictors and timing.
    Sørensen JØ; Rasmussen A; Roesbjerg T; Verhulst FC; Pagsberg AK
    Acta Psychiatr Scand; 2022 Feb; 145(2):209-222. PubMed ID: 34374070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adolescent angst or true intent? Suicidal behavior, risk, and neurobiological mechanisms in depressed children and teenagers taking antidepressants.
    Morrison J; Schwartz TL
    Int J Emerg Ment Health; 2014; 16(1):247-50. PubMed ID: 25345238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets.
    Gibbons RD; Brown CH; Hur K; Marcus SM; Bhaumik DK; Mann JJ
    Am J Psychiatry; 2007 Jul; 164(7):1044-9. PubMed ID: 17606656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal.
    Cosci F; Chouinard VA; Chouinard G
    Psychother Psychosom; 2024 Jul; ():1-6. PubMed ID: 39043160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential involvement of NET polymorphism in serotonin/norepinephrine reuptake inhibitor response in panic disorder.
    Park HJ; Kim SK; Kang WS; Kim YJ; Cho AR; Park JK
    Nord J Psychiatry; 2016; 70(4):314-7. PubMed ID: 26508020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressants use in pediatric populations.
    Gören JL
    Expert Opin Drug Saf; 2008 May; 7(3):223-5. PubMed ID: 18462180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant Tolerability in Pediatric Anxiety and Obsessive-Compulsive Disorders: A Bayesian Hierarchical Modeling Meta-analysis.
    Mills JA; Strawn JR
    J Am Acad Child Adolesc Psychiatry; 2020 Nov; 59(11):1240-1251. PubMed ID: 31682918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID-19 patients: A systematic review and meta-analysis.
    Firouzabadi D; Kheshti F; Abdollahifard S; Taherifard E; Kheshti MR
    Health Sci Rep; 2022 Nov; 5(6):e892. PubMed ID: 36268458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits.
    Molina KC; Fairman KA; Sclar DA
    Drug Healthc Patient Saf; 2018; 10():37-43. PubMed ID: 29760569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fluoxetine: an update of its use in major depressive disorder in adults].
    Gourion D; Perrin E; Quintin P
    Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.
    Gibbons RD; Brown CH; Hur K; Marcus SM; Bhaumik DK; Erkens JA; Herings RM; Mann JJ
    Am J Psychiatry; 2007 Sep; 164(9):1356-63. PubMed ID: 17728420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
    Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.